Kancera AB operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kancera AB with three other
pharmaceutical manufacturers in Europe:
NUTEX Investments Plc
sales of 8.76 million Hungarian Forints [US$31,448.40 ]
Bone Therapeutics SA
(41,000.00 Euro [US$47,453.81 ]
Infant Bacterial Therapeutics AB
(238,000.00 Swedish Kronor [US$26,582.22 ]
Kancera AB reported sales of SEK 376,000.00 (US$42.00 thousand)
December of 2017.
increase of 22.1%
versus 2016, when the company's sales were SEK 308,000.00 .